Overview / Abstract: |
Target Audience This activity is intended for radiologists, pulmonologists, cardiologists, and other allied healthcare practitioners managing patients with suspected PAH. Program Overview Don’t delay the diagnosis of PAH or overlook high-risk patients who should be screened. Dr. Ryan approaches this activity through a test first model. The learner is challenged with clinical scenarios via ECHO images and interactive questions, then commentary, recommendations, and strategies are provided by the faculty to apply in practice to improve patient outcomes. Learning Objectives Upon completion of this activity, participants will be able to: Discuss the current role of imaging in the diagnosis and management of PAH |
Expiration |
Aug 31, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.75 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., PAH Free CE CME |